TY  - GEN
AU  - Darrah,Rebecca J
AU  - Jacono,Frank J
AU  - Joshi,Neha
AU  - Mitchell,Anna L
AU  - Sattar,Abdus
AU  - Campanaro,Cara K
AU  - Litman,Paul
AU  - Frey,Jennifer
AU  - Nethery,David E
AU  - Barbato,Eric S
AU  - Hodges,Craig A
AU  - Corvol,Harriet
AU  - Cutting,Garry R
AU  - Knowles,Michael R
AU  - Strug,Lisa J
AU  - Drumm,Mitchell L
TI  - AGTR2 absence or antagonism prevents cystic fibrosis pulmonary manifestations
SN  - 1873-5010
PY  - 2020///0421
KW  - Angiotensin II Type 2 Receptor Blockers
KW  - pharmacology
KW  - Animals
KW  - Child
KW  - Cystic Fibrosis
KW  - complications
KW  - DNA
KW  - genetics
KW  - DNA Mutational Analysis
KW  - Disease Models, Animal
KW  - Female
KW  - Follow-Up Studies
KW  - Forced Expiratory Flow Rates
KW  - physiology
KW  - Genotype
KW  - Humans
KW  - Imidazoles
KW  - Lung
KW  - physiopathology
KW  - Lung Diseases
KW  - etiology
KW  - Male
KW  - Mice
KW  - Mice, Knockout
KW  - Mutation
KW  - Pyridines
KW  - Receptor, Angiotensin, Type 2
KW  - drug effects
KW  - Retrospective Studies
N1  - Publication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, Non-P.H.S
UR  - https://doi.org/10.1016/j.jcf.2018.05.013
ER  -